Cancer Research Advances Highlight Incremental Progress in Treatment
Recent advancements in cancer research have shown promising developments in detection methods, drugs, and treatments. Survival rates in the UK have doubled since the 1970s, and Michelle Mitchell of Cancer Research UK highlights a 'golden age' for cancer research, marked by incremental progress rather than a singular breakthrough. A new drug, daraxonrasib, has shown promise in doubling survival time for pancreatic cancer patients, and new immunotherapies are being developed to spare bladder cancer patients from invasive surgeries. These developments were discussed at the American Society of Clinical Oncology meeting in Chicago. 
